Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Moritz

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Journal of Telemedicine and Telecare|May 14, 2013
Clinical course outcomes for store and forward teledermatology versus conventional consultation: a randomized trialJohn D Whited, Erin M Warshaw, Kush Kapur, et al.
Diabetes|August 5, 2009
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosisPeter D Reaven, Thomas E Moritz, Dawn C Schwenke, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptorsJuan Enriquez-Traba, Hector E Yarur-Castillo, Rodolfo J Flores, et al.
JAMA Dermatology|February 22, 2013
Effect of store and forward teledermatology on quality of life: a randomized controlled trialJohn D Whited, Erin M Warshaw, Karen E Edison, et al.
Standards in Genomic Sciences|June 8, 2012
Complete Genome Sequence of a thermotolerant sporogenic lactic acid bacterium, Bacillus coagulans strain 36D1Mun Su Rhee, Brélan E Moritz, Gary Xie, et al.
Diabetologia|August 6, 2009
Intensive glucose control and macrovascular outcomes in type 2 diabetes, F M Turnbull, C Abraira, et al.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 2026
Decreases in human papillomavirus vaccine types 16 and 18 in cervical precancers - HPV-IMPACT, 2008-2019Ruth Stefanos, Julia W Gargano, Linda M Niccolai, et al.
Molecular Psychiatry|May 29, 2025
Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variantFelix P Mayer, Adele Stewart, Durairaj Ragu Varman, et al.
Nature Neuroscience|December 9, 2024
Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptorsJuan Enriquez-Traba, Miguel Arenivar, Hector E Yarur-Castillo, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Journal of Telemedicine and Telecare|May 14, 2013
Clinical course outcomes for store and forward teledermatology versus conventional consultation: a randomized trialJohn D Whited, Erin M Warshaw, Kush Kapur, et al.
Diabetes|August 5, 2009
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosisPeter D Reaven, Thomas E Moritz, Dawn C Schwenke, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptorsJuan Enriquez-Traba, Hector E Yarur-Castillo, Rodolfo J Flores, et al.
JAMA Dermatology|February 22, 2013
Effect of store and forward teledermatology on quality of life: a randomized controlled trialJohn D Whited, Erin M Warshaw, Karen E Edison, et al.
Standards in Genomic Sciences|June 8, 2012
Complete Genome Sequence of a thermotolerant sporogenic lactic acid bacterium, Bacillus coagulans strain 36D1Mun Su Rhee, Brélan E Moritz, Gary Xie, et al.
Diabetologia|August 6, 2009
Intensive glucose control and macrovascular outcomes in type 2 diabetes, F M Turnbull, C Abraira, et al.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 2026
Decreases in human papillomavirus vaccine types 16 and 18 in cervical precancers - HPV-IMPACT, 2008-2019Ruth Stefanos, Julia W Gargano, Linda M Niccolai, et al.
Molecular Psychiatry|May 29, 2025
Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variantFelix P Mayer, Adele Stewart, Durairaj Ragu Varman, et al.
Nature Neuroscience|December 9, 2024
Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptorsJuan Enriquez-Traba, Miguel Arenivar, Hector E Yarur-Castillo, et al.
Pageof 22